Literature DB >> 24916482

Acute respiratory distress syndrome (ARDS) treated successfully by veno-venous extracorporeal membrane oxygenation (ECMO) in a nearly drowned patient.

Tomohiro Sonoo1, Kazuma Ohshima, Hiroaki Kobayashi, Toshifumi Asada, Takahiro Hiruma, Kento Doi, Masataka Gunshin, Tomohiro Murakawa, Masaki Anraku, Susumu Nakajima, Jun Nakajima, Naoki Yahagi.   

Abstract

This report highlights about one acute respiratory distress syndrome (ARDS) case after near-drowning resuscitated using extracorporeal membrane oxygenation (ECMO). Few cases have been reported about ECMO use for near-drowning and in most of these cases, ECMO was initiated within the first week. However, in our report, we would like to emphasize that seemingly irreversible secondary worsening of ARDS after nearly drowned patient was successfully treated by ECMO use more than 1 week after near-drowning followed by discharge without home oxygen therapy, social support, or any complication. This is probably due to sufficient lung rest for ventilator-associated lung injury during ECMO use. Based on our case's clinical course, intensive care unit physicians must consider ECMO even in the late phase of worsened ARDS after near-drowning.

Entities:  

Mesh:

Year:  2014        PMID: 24916482     DOI: 10.1007/s10047-014-0776-y

Source DB:  PubMed          Journal:  J Artif Organs        ISSN: 1434-7229            Impact factor:   1.731


  8 in total

Review 1.  Drowning.

Authors:  David Szpilman; Joost J L M Bierens; Anthony J Handley; James P Orlowski
Journal:  N Engl J Med       Date:  2012-05-31       Impact factor: 91.245

2.  Drowning. Its clinical sequelae and management.

Authors:  J F Rivers; G Orr; H A Lee
Journal:  Br Med J       Date:  1970-04-18

3.  Secondary drowning in children.

Authors:  J H Pearn
Journal:  Br Med J       Date:  1980-10-25

Review 4.  Extracorporeal membrane oxygenation for ARDS in adults.

Authors:  Daniel Brodie; Matthew Bacchetta
Journal:  N Engl J Med       Date:  2011-11-17       Impact factor: 91.245

5.  Mortality is directly related to the duration of mechanical ventilation before the initiation of extracorporeal life support for severe respiratory failure.

Authors:  T Pranikoff; R B Hirschl; C N Steimle; H L Anderson; R H Bartlett
Journal:  Crit Care Med       Date:  1997-01       Impact factor: 7.598

6.  Extracorporeal life support for 100 adult patients with severe respiratory failure.

Authors:  S Kolla; S S Awad; P B Rich; R J Schreiner; R B Hirschl; R H Bartlett
Journal:  Ann Surg       Date:  1997-10       Impact factor: 12.969

7.  Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial.

Authors:  Giles J Peek; Miranda Mugford; Ravindranath Tiruvoipati; Andrew Wilson; Elizabeth Allen; Mariamma M Thalanany; Clare L Hibbert; Ann Truesdale; Felicity Clemens; Nicola Cooper; Richard K Firmin; Diana Elbourne
Journal:  Lancet       Date:  2009-09-15       Impact factor: 79.321

8.  The Italian ECMO network experience during the 2009 influenza A(H1N1) pandemic: preparation for severe respiratory emergency outbreaks.

Authors:  Nicolò Patroniti; Alberto Zangrillo; Federico Pappalardo; Adriano Peris; Giovanni Cianchi; Antonio Braschi; Giorgio A Iotti; Antonio Arcadipane; Giovanna Panarello; V Marco Ranieri; Pierpaolo Terragni; Massimo Antonelli; Luciano Gattinoni; Fabrizio Oleari; Antonio Pesenti
Journal:  Intensive Care Med       Date:  2011-07-06       Impact factor: 17.440

  8 in total
  2 in total

1.  Journal of Artificial Organs 2014: the year in review.

Authors:  Y Sawa; K Matsuda; E Tatsumi; G Matsumiya; T Abe; K Fukunaga; A Kishida; K Kokubo; T Masuzawa; A Myoui; M Nishimura; T Nishimura; T Nishinaka; E Okamoto; S Tokunaga; T Tomo; T Tsukiya; Y Yagi; T Yamaoka
Journal:  J Artif Organs       Date:  2015-02-21       Impact factor: 1.731

2.  Veno-venous extracorporeal membrane oxygenation (ECMO) for acute respiratory failure caused by liver abscess.

Authors:  Kazuhiro Katsuhara; Taka-Aki Nakada; Mami Yamada; Takashi Fuse; Koji Idoguchi; Tetsuya Matsuoka
Journal:  J Artif Organs       Date:  2014-11-25       Impact factor: 1.731

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.